Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
TELA
Deeply undervalued
TELA Bio, Inc.
Price$1.05
Model IV$6.38
P/IV0.15
Discount 84%
Return to IV: +507.1%
Market implies -41.0%/yr
vs model +28.5% · below model
TFX
Deeply overvalued
TELEFLEX INC
Price$124.19
Model IV$61.35
P/IV2.10
Premium +102%
Return to IV: -50.6%
Market implies +7.5%/yr
vs model +2.0% · above model
TLSI
Deeply overvalued
TriSalus Life Sciences, Inc.
Price$4.13
Model IV$1.56
P/IV2.19
Premium +166%
Return to IV: -62.3%
Market implies +9.4%/yr
vs model +15.0% · below model
TLSIW
Fairly valued
TriSalus Life Sciences, Inc.
Price$0.98
Model IV$1.05
P/IV0.76
Discount 7%
Return to IV: +7.2%
Market implies -5.5%/yr
vs model +15.0% · below model
TMCI
Deeply overvalued
TREACE MEDICAL CONCEPTS, INC.
Price$3.88
Model IV$2.66
P/IV1.30
Premium +46%
Return to IV: -31.3%
Market implies +7.4%/yr
vs model +22.5% · below model
TMDX
Deeply overvalued
TransMedics Group, Inc.
Price$79.00
Model IV$41.72
P/IV1.61
Premium +89%
Return to IV: -47.2%
Market implies +17.0%/yr
vs model +10.0% · above model
TNDM
Deeply undervalued
TANDEM DIABETES CARE INC
Price$15.68
Model IV$23.66
P/IV0.69
Discount 34%
Return to IV: +50.9%
Market implies -9.8%/yr
vs model +9.6% · below model
TNON
Valuation N/A
Tenon Medical, Inc.
Price$3.44
Model IV—
P/IV—
Market implies +88.1%/yr
UFPT
Deeply undervalued
UFP TECHNOLOGIES INC
Price$286.56
Model IV$446.42
P/IV0.49
Discount 36%
Return to IV: +55.8%
Market implies +11.5%/yr
vs model +24.5% · below model
UTMD
Deeply overvalued
UTAH MEDICAL PRODUCTS INC
Price$73.88
Model IV$56.27
P/IV1.33
Premium +31%
Return to IV: -23.8%
Market implies +6.1%/yr
vs model +5.2% · in line
VANI
Valuation N/A
Vivani Medical, Inc.
Price$1.23
Model IV—
P/IV—
Limited data — see page
VTAK
Valuation N/A
Catheter Precision, Inc.
Price$1.01
Model IV—
P/IV—
Market implies -39.8%/yr
VVOS
Deeply undervalued
Vivos Therapeutics, Inc.
Price$0.15
Model IV$1.04
P/IV0.67
Discount 86%
Return to IV: +597.3%
Market implies -43.8%/yr
vs model +2.0% · below model
WOK
Fairly valued
WORK Medical Technology Group LTD
Price$1.52
Model IV$1.61
P/IV0.06
Discount 6%
Return to IV: +6.1%
Market implies -3.1%/yr
vs model +2.0% · below model
WRBY
Valuation N/A
Warby Parker Inc.
Price$24.95
Model IV—
P/IV—
Market implies +56.3%/yr
vs model +11.9% · above model
WST
Deeply overvalued
WEST PHARMACEUTICAL SERVICES INC
Price$363.27
Model IV$147.10
P/IV2.56
Premium +147%
Return to IV: -59.5%
Market implies +17.9%/yr
vs model +7.6% · above model
XAIR
Deeply overvalued
Beyond Air, Inc.
Price$2.31
Model IV$0.64
P/IV4.72
Premium +262%
Return to IV: -72.4%
Market implies +16.0%/yr
vs model +15.0% · in line
XRAY
Deeply overvalued
DENTSPLY SIRONA Inc.
Price$8.69
Model IV$4.64
P/IV2.26
Premium +87%
Return to IV: -46.6%
Market implies +13.6%/yr
vs model +5.5% · above model
XTNT
Deeply undervalued
Xtant Medical Holdings, Inc.
Price$0.32
Model IV$1.96
P/IV0.24
Discount 84%
Return to IV: +511.7%
Market implies -10.9%/yr
vs model +20.3% · below model
ZBH
Deeply undervalued
ZIMMER BIOMET HOLDINGS, INC.
Price$88.88
Model IV$203.72
P/IV0.40
Discount 56%
Return to IV: +129.2%
Market implies -4.1%/yr
vs model +7.8% · below model
ZJYL
Valuation N/A
Jin Medical International Ltd.
Price$2.12
Model IV—
P/IV—
Market implies +54.9%/yr
vs model +2.0% · above model